Using available evidence to inform a prioritized and patient-centred National Strategic Plan - Maureen Kamene
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Using available evidence to inform a prioritized and patient-centred National Strategic Plan Maureen Kamene
NSP 2015-2018 Evidence-based plan Strategic Priorities Evidence was epidemiological and related to 1. Identify and treat all cases Everything was 1. Core DOTS equally “prioritized” programmatic performance 2. MDR-TB 3. Pediatric TB 4. Leprosy 2. Engage all care providers 3. Promote and strengthen community engagement 4. Enhance the multi-sectoral response to TB/HIV 5. Accelerate appropriate diagnosis 6. Ensure stable & quality supply of all commodities 7. Enhance evidence-based programme monitoring & evaluation 8. Create an enabling, multi-sectoral environment 9. Support devolution
NSP Development Process NSP 2015 – 2018 Global Fund We thought we knew the epi. We planned using it. application 1. Identify and treat all cases 1. Core DOTS 2. MDR-TB What’s New? 3. Pediatric TB 4. Leprosy Prevalence survey • more TB than previously 2. Engage all care providers estimated 3. Promote and strengthen community • non-specific symptoms & engagement asymptomatic TB 4. Enhance the multi-sectoral response to TB/HIV 5. Accelerate appropriate diagnosis Patient pathway analysis 6. Ensure stable & quality supply of all • people with TB in the health commodities system, undiagnosed 7. Enhance evidence-based programme monitoring & evaluation Etc. 8. Create an enabling, multi-sectoral environment 9. Support devolution
NSP Development Process NSP 2015 – 2018 NSP 2018 - 2023 We thought we knew the epi. We know more about the epi. We planned using it. Now we know about patient behavior. We can plan to local patient needs. 1. Identify and treat all cases 1. Core DOTS 2. MDR-TB 3 ways this NSP can be ground-breaking: What’s New? 3. Pediatric TB 4. Leprosy Prevalence survey 1. Use consolidated national data to incorporate • more TB than previously a robust evidence base to establish priorities 2. Engage all care providers estimated for action 3. Promote and strengthen community Patient pathway analysis engagement • people with TB in the health 4. Enhance the multi-sectoral response to 2. Use sub-national data to build a plan that system, undiagnosed TB/HIV responds to county-specific needs and 5. Accelerate appropriate diagnosis Adherence study successes 6. Ensure stable & quality supply of all commodities Inventory study 3. Use impact evaluations and modeling to • Many patients on care, not optimize the effectiveness of packages of 7. Enhance evidence-based programme notified monitoring & evaluation interventions 8. Create an enabling, multi-sectoral Epi review environment enabling a prioritized / tiered plan 9. Support devolution 4
Framework for prioritization and planning Reviewing the evidence about the biggest epidemiological challenges and the biggest challenges on a patient’s pathway to care can help to identify which sets of problems should be priorities for the national TB program Pre-work Day 1 Day 2 Day 3 1. Problem 2. Root Cause 3. Intervention People are in Prioritization Analysis Identification the health system, but not notified/ People don’t diagnosed make it to the What What are health system What was Which contributes to priority Implement the impact of are the biggest the problem? solutions to the best People with these problems? What does it optimize solutions TB are look like? solutions? impact? notified, but not cured 5
Framework for prioritization and planning Reviewing the evidence about the biggest epidemiological challenges and the biggest challenges on a patient’s pathway to care can help to identify which sets of problems should be priorities for the national TB program Pre-work 1. Problem 2. Root Cause 3. Intervention People are in Prioritization Analysis Identification the health system, but not notified/ People don’t diagnosed make it to the What What are health system What was Which contributes to priority Implement the impact of are the biggest the problem? solutions to the best People with these problems? What does it optimize solutions TB are look like? solutions? impact? notified, but not cured 6
National data and evidence compiled (1/2) Resource Title Year Problem Root Cause Analysis Solution Prioritization Optimization Surveillance, Surveys and Studies TB Surveillance Data (TIBU) All X X TB Prevalence Survey 2015/2016^ 2016 X X Adherence survey 2017^ 2017 X TB Patient cost survey 2017^ 2017 X Inventory study 2014/2015^ 2016 X X Drug resistant survey 2014/2015 2015 X Delay in Diagnosis 2013/2014* 2014 X Kenya Demographic and Health survey (KDHS) 2013^ 2013 X X KAIS 2012* 2012 X X GXpert Impact survey 2017* 2017 X X Community survey 2017* 2017 X Keheala study to improve Treatment Adherence* 2017 X X SARAM Survey 2013 2013 X X X Health Expenditure Utilization Survey 2016 2016 X X Analyses Patient Pathway analysis 2017^ 2017 X X Legal environmental assessment by KELIN 2017* 2017 X X Data for action for Key, Vulnerable and underserved population X X 2018 by Kelin 2017/2018* Gender barriers to TB by KELIN 2017* 2018 X TB/DM by AMPATH* 2017 X 7
NATIONAL DATA AND EVIDENCE COMPILED (2/2) Resource Title Year Problem Prioritization Root Cause Analysis Solution Optimization Reviews/Reports WHO Global TB Report 2017^ 2017 X GF concept note 2017 X NTLDP Annual report 2017 2018 X Mid term review 2017 2017 X X Epi Review 2017^ 2017 X X ACF Experience sharing report 2017 2017 X X GLC AFRO Mission Kenya Report 2017 2017 X Policy Documents Kenya Health Sector Strategic and Investment Plan 2013-2017 2013 X END TB Strategy 2015 X Isolation policy 2018 X Social protection policy 2018 X Sustainability framework 2017 X Investment case 2017 X NSP 2015-2018 2015 X 8
DATA AND EVIDENCE MAPPED TO THE CARE CONTINUUM Epi Priority setting requires : Know your epidemiology, know your patient, know your system Patient People don’t make it to the health system People with TB in the health system, but not People with TB are notified, notified/diagnosed but not cured People with Total Asymptomatic Symptomatic Presenting to Diagnosed by Diagnosed by TB infection, Notified, not Durable cure disease, not disease, not health facilities, non-NTP, not NTP, not high-risk for durable cure (relapse free) seeking care seeking care not diagnosed notified notified disease 5 6 DS-TB 1 2 DR-TB 3 4 TB/HIV Epi Total # Important metrics from available evidence resources (see following slides) 9
EXAMPLE: EVIDENCE INPUT INTO THE CARE CONTINUUM (1/2) 2016 Prevalence Survey 5 Asymptomatic disease, not seeking care Screening for TB using any or all of the four cardinal symptoms - cough of more than two weeks, fever, night sweats and weight loss - would have missed 40% of the TB cases 6 Symptomatic disease, not seeking 5 care Majority of people found to have TB had not sought health care for their symptoms 6 prior to the survey – Majority did not seek health care because they did not perceive their symptoms as being serious 10
EXAMPLE: EVIDENCE INPUT INTO THE CARE CONTINUUM (1/2) 2017 Patient Pathway Analysis 1 3 Presenting to health facilities, not diagnosed 43% of people with TB are likely to visit a health facility with capacity for TB diagnosis on their first visit to the health care system. Even fewer are likely to 2 receive a DR diagnosis on their first visit. 4 2 4 Diagnosed by non-NTP, not notified Over 40% of people initiate their care seeking journey in private (formal or informal) facilities. Diagnostic capacity exists in the private sector, however only notifications from the private sector only account for 13% of the estimated burden. 1 3 11
Evidence Review Sessions Patient People with TB in the health system, but not People Who aren’t in the health system People with TB are notified, but not cured notified/diagnosed High-risk for TB Asymptomatic Symptomatic Session 1 Presenting to Diagnosed by Diagnosed by People with TB On treatment Complete Tx, infection, or disease, not disease, not Burden of health facilities, private sector, not public sector, not notified to the without w/out durable, breakdown to seeking care seeking care Disease not diagnosed notified notified NTP treatment success relapse-free cure disease DS-TB* Session 3 – Evidence related to people Session 2 – Evidence related to people Session 4 – Evidence related to people not in the health system DR-TB in the health system not being who are notified, but not cured diagnosed/notified TB/HIV Epi 1 2
WORKING GROUPS ACCESSED DATA / EVIDENCE SUMMARY SHEETS Session 3 – People Session 4 – people Session 1 – Burden Session 2 – People in system, not notified, but not of Disease not in health system notified/dx cured # 2016 Prevalence Survey # 2017 WHO TB Report # 2014 DHS # 2016 Inventory Study # 2017 Patient Pathway Analysis # 2017 Epi Review # 2013 HEUS 13
Session 1: Data TEAMS DEALT WITH DISCORDANT DATA 1 EXAMPLE: 2016 PREVALENCE SURVEY [TB/HIV] • Among prevalent TB patients in the prevalence survey, 13.4% were recorded in TIBU as HIV(+), while 23% of these patients self-reported as HIV(+) 1 1 14
Session 1: Data 2017 WHO GLOBAL TB REPORT [TB/HIV] • According to the WHO report, 96% 10 of patients have known HIV status, and 31% of patients with known HIV 10 status are HIV-positive; 10 15
WORKING GROUP: DISCUSSION PROMPTS Review available data and establish a level of priority based on the evidence Comment on the quality of data 1. How big of a problem is this, within the context of the overall TB burden? Either (rank between 1-5; 1=not a big problem, low priority; 5= top priority) Sufficient to establish a level of priority 2. To what extent is there progress against this challenge Or (1=no progress; 5 = solid progress, commensurate with problem) Additional data are available and need to be included 3. What level of priority should be given to filling the remaining gaps related to this challenge? Or (1=not a big problem, low priority; 5= top priority) Data gaps - - Define © 2017 Bill & Melinda Gates Foundation | 16
Working group priority scores were consolidated 17
Inventory of Evidence Gaps was compiled Priorities based on available data But…. Insufficient data in some instances So…. Reconsider based on available evidence from newly identified sources or Add to research agenda
FRAMEWORK FOR PRIORITIZATION AND PLANNING Step-wise approach to strategic planning that focuses on where people with TB may be “missing” from care 1. Problem 2. Root Cause 3. Intervention People are in Prioritization Analysis Optimization the health system, but not notified/ People don’t diagnosed make it to the What are What What was health system Which priority Implement contributes to the impact of are the biggest the problem? solutions to the best People with these problems? What does it optimize solutions TB are look like? solutions? impact? notified, but not cured 19
Participants were introduced to Root Cause analysis Understanding the layers and determinants that contribute to priority challenges Known priority problem Determinants Root cause 1. What is known about the factors contributing to this problem? 2. What additional evidence is needed to better understand the root cause of this Interventions to address problem? determinants 3. Which can feasibly be addressed? 2 0
ROOT CAUSE ANALYSIS Additional data were made available to assist working groups to think about determinants and root causes Patient People Who aren’t in the health system People with TB in the health system, but People with TB are notified, but not cured not notified/diagnosed High-risk for Presenting to On treatment Complete Tx, Asymptomatic Symptomatic Diagnosed by Diagnosed by People with TB TB infection, health without w/out durable, disease, not disease, not private sector, public sector, notified to the or breakdown facilities, not treatment relapse-free seeking care seeking care not notified not notified NTP to disease diagnosed success cure 1 1 1 2 4 1 1 1 5 DS-TB 2 3 5 2 1 2 2 6 2 3 3 7 DR-TB 4 4 8 TB/HIV Epi # 2016 Prevalence Survey # 2017 WHO TB Report # 2014 DHS # 2016 Inventory Study # 2017 Patient Cost Survey # 2017 Patient Pathway Analysis # 2017 Epi Review # 2013 HEUS # 2017 Adherence Study 21
EXAMPLE: 2017 ADHERENCE STUDY •1 There was a statistically increased risk of non- adherence in the groups 25-34, 35-44 and 55-64 years compared to age group 18-14 years (p
ROOT CAUSE ANALYSIS Small working groups can map what is known / what evidence is still needed to inform evidence-based action - What is known about the factors contributing to this problem? - What additional evidence is needed to better understand the root cause of this problem? - Of the possible root causes, which would be the most impactful to address? Which can feasibly be addressed? People with TB in the health system, but Group 6: People Who aren’t in the health system People with TB are notified, but not cured not notified/diagnosed Patient DR-TB High-risk for Presenting to On treatment Complete Tx, Asymptomatic Symptomatic Diagnosed by Diagnosed by People with TB TB infection, health without w/out durable, disease, not disease, not private sector, public sector, notified to the Group 7: TB or breakdown seeking care seeking care facilities, not not notified not notified NTP treatment relapse-free in children to disease diagnosed success cure Group 8: Group 4 – Key M&E, populations Group 2 – Group 3 – including Group 5 – Ensuring cure, including Group 1 – Pre-care seeking, diagnostic Private initial Group 9: treatment support and social protection including community engagement gap and sector and default TB/HIV PAL (lab) and Epi not notified Group 10: Leprosy 23
Lack of knowledge of TB among HCWs No or Inadequate training Lack of pre-service Lack of OJT Focus only on TB training on TB Rx sites – 40% - Outdated Curriculum - Lack of need assessment for training - Supervision based on case notification - Lack of engagement by by counties - Lack of policy on pre-Dx cascade NTP - Lack of advocacy to donors & counties - Lack of M&E tools - Lack of multi-sectoral - Lack of measurement of training - Lack of evidence on importance of pre- approach impact Dx prior to prevalence survey Patients visit the HF, not screened for TB - Inadequate quantification to - Inability to plan around long allow accurate forecasting - Lack of mechanisms procurement cycles - Forecasting based on at county level for - Multiple donors/partners with notification data not distribution of tools different cycles/roles presumptive Stationary Distribution of tools Long TAT printing not not prioritized by for printing done in time counties tools Tools for specimen collection not available
FRAMEWORK FOR PRIORITIZATION AND PLANNING Step-wise approach to strategic planning that focuses on where people with TB may be “missing” from care 1. Problem 2. Root Cause 3. Intervention People are in Prioritization Analysis Optimization the health system, but not notified/ People don’t diagnosed make it to the What are What What was health system Which priority Implement contributes to the impact of are the biggest the problem? solutions to the best People with these problems? What does it optimize solutions TB are look like? solutions? impact? notified, but not cured 26
Group: Not complete treatment (Treatment, UHC and social support) Action Domain: Nutrition support Objectives: • Improve treatment outcome of patients with malnutrition (% death, % LTFU) ✓ All HCWs managing TB patients are competent in assessing and managing malnourished TB patients ✓ All TB patients are assessed for nutritional status (100%) ✓ All TB patients are provided with nutrition support according to their needs (100% for SAM, …) High Feasibility 1. Universal nutritional assessment 3. Boldly address supply chain and counselling management issues of nutritional 1 • ~18% patient not evaluated commodities up to beneficiary 4 3 • Systematic nutrition assessment at the • Align supply of TB drugs to nutritional 2 start of treatment, follow up and at the commodities end of treatment • (Being the biggest constraint for the Low • System to alert if no improvement intervention 2) Impact High Impact 2. Universal nutrition management 4. Impact evaluation of nutrition for all eligible patients interventions • ~20% SAM; ~30% MAM • Compilation of existing evidence • Micronutrient supplementation • Establish a robust impact Others- • Therapeutic feeding for SAM • Multi-sector collaboration evaluation framework • Case detection in other in-country • Supplemental feeds for MAM nutritional interventions eg school, community, LowMUAC screening Feasibility
Key Results 1. Results along the care continuum can be used as the context for understanding new data / evidence 2. Priorities established based on evidence, rather than politics or emotions 3. Interventions identified that target the most important determinants / root causes of remaining challenges 4. Priority data/evidence gaps documented; filling these gaps will direct impact the ability of the programme to make informed decisions 2 8
Current thinking: NSP framework 2019-2023 3. Inclusion of TB, Strategic 1. Close the gaps along 2. Differentiated 4. Prevent infection, 5. Patient centered Leprosy and Lung objectives for TB, the care continuum to response by county active disease, approach that Disease within Leprosy and Lung find and cure the to address TB in the morbidity and promotes quality of National UHC Disease missing cases local context mortality care framework 29
Next steps 1. Problem 2. Root Cause 3. People are in the Prioritization Analysis Intervention health Identification People system, but don’t make not notified/ it to the diagnosed What are health Which What What was contributes to priority Implement are the the impact system People with biggest the problem? solutions to the best of these Preliminary national-level priorities What does it optimize solutions TB are problems? look like? solutions? notified, but impact? not cured 1. Refine at national level using additional available evidence 2. Repeat with counties to identify sub-national priorities 3. Conduct patient and health worker focus groups 4. Triangulate for evidence-based NSP 3 0
National Tuberculosis, Leprosy and Lung Disease Program Email: mkamene@nltp.co.ke nltp.co.ke @NTLDKenya NTLDKenya Asante (Thank You)!
You can also read